مباشر
FierceBiotechIndivior warns of ‘significant impact’ on R&D team after opioid use disorder drug fails phase 2FierceBiotechBMS calls time on Zymeworks collab, ending work on phase 1 cancer bispecificEndpoints NewsWhat we heard at a health tech conference in BostonPromega BlogThe Filter You Didn’t ChooseFierceBiotechLabcorp raises full-year guidance, boosted by diagnostics, lab servicesFierceBiotechLeo Pharma pays $50M for Replay and its preclinical skin disease gene therapyEndpoints NewsCVS' healthcare delivery chief eyes potential in clinical AIPharmaVoicePfizer deals extend patent life for a top-selling rare disease drugFierceBiotechBeOne signs $2B deal for option on preclinical trispecific antibody from China’s HuahuiBioWorldMFDS clears Curocell’s anbal-cel as first homegrown CAR T therapyCytiva (Google News)Rockwell Automation and Cytiva launch Figurate SCADA system to eliminate digital bottlenecks in biopharmaceutical manufacturing - Manufacturing ChemistEndpoints NewsLack of specifics on obesity pill sales hover over Lilly’s first quarter
Carl Zeiss(Shanghai)Co.,Ltd ٢١ ديسمبر ٢٠٢١

illumiSonics Inc. Expands Its Executive Management With the Appointment of Jochen Schweizer as Chief Operating Officer - newswire.com

illumiSonics Inc. Expands Its Executive Management With the Appointment of Jochen Schweizer as Chief Operating Officer - newswire.com

المحتوى غير متاح. يرجى الرجوع إلى المصدر الأصلي.